Generation bio announces plan to scale next-generation rapid enzymatic manufacturing process across portfolio and provides pipeline update

Company to transition all portfolio programs to rapid enzymatic synthesis (res), enabling improved quality, scale and speed of closed-ended dna manufacturing

GBIO Ratings Summary

GBIO Quant Ranking